title: MEN syndromes.
abstract: MEN1 and MEN2 are rare inherited cancer syndromes which express a variety of endocrine and nonendocrine tumors. The improved knowledge of molecular and clinical physiopathology of MEN syndromes, together with the availability of genetic testing, have led to earlier detection and intervention, with consequent reduction of mortality and morbidity for MEN-associated tumors. Genetic testing has gained a key role in the detection of asymptomatic patients harbouring mutations responsible for these syndrome, and allows institution of early and tailored intervention with a positive impact on the course of disease.
authors.affiliation: Department of Internal Medicine, University of Florence and Regional Centre for Hereditary Endocrine Tumors, Unit of Metabolic Bone Diseases, Florence, Italy.
authors.forename: Alberto
authors.initials: A
authors.lastname: Falchetti
mesh_terms: D055088:Early Detection of Cancer; D005820:Genetic Testing; D006801:Humans; D009377:Multiple Endocrine Neoplasia / Q000175:diagnosis* / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy; D018761:Multiple Endocrine Neoplasia Type 1 / Q000175:diagnosis / Q000235:genetics; D018813:Multiple Endocrine Neoplasia Type 2a / Q000175:diagnosis / Q000235:genetics; D009154:Mutation